Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Operable Breast Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 13 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT00010153
What this trial is testing

ICI 182780 in Treating Women With Stage I or Stage II Primary Breast Cancer

Who this might be right for
Breast Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Large-scale testing (Phase 3)Study completedNCT03969121
What this trial is testing

Neoadjuvant Hormonal Therapy Plus Palbociclib in Operable, Hormone Sensitive and HER2-Negative Primary Breast Cancer

Who this might be right for
Breast Cancer FemaleHormone Receptor Positive Malignant Neoplasm of Breast
Kyoto Breast Cancer Research Network 141
Testing effectiveness (Phase 2)Study completedNCT00559754
What this trial is testing

Avastin (Bevacizumab) and Sequential Chemotherapy in Patients With Primary HER2 Negative Operable Breast Cancer.

Who this might be right for
Breast Cancer
Hoffmann-La Roche 72
Testing effectiveness (Phase 2)Looking for participantsNCT02476786
What this trial is testing

Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence Score

Who this might be right for
Breast CancerCancer of BreastBreast Neoplasms+1 more
Washington University School of Medicine 50
Large-scale testing (Phase 3)UnknownNCT00003679
What this trial is testing

Combination Chemotherapy in Treating Women With Breast Cancer

Who this might be right for
Breast Cancer
Scottish Cancer Therapy Network 350
Testing effectiveness (Phase 2)Study completedNCT02760030
What this trial is testing

Endocrine Therapy Fulvestrant & Palbociclib or Aromatase Inhibitor Therapy in Treating Older Patients With Hormone Responsive Breast Cancer That Cannot Be Removed by Surgery

Who this might be right for
Estrogen Receptor and/or Progesterone Receptor PositiveHER2/Neu NegativeStage IA Breast Cancer+6 more
Ohio State University Comprehensive Cancer Center 14
Testing effectiveness (Phase 2)Study completedNCT00532857
What this trial is testing

Phase II Study of Primary Chemotherapy With Paclitaxel, Gemcitabine, and Trastuzumab

Who this might be right for
Breast Cancer
Jungsil Ro 53
Early research (Phase 1)Study completedNCT00008034
What this trial is testing

Combination Chemotherapy Before Surgery in Treating Women With Breast Cancer

Who this might be right for
Breast Cancer
European Organisation for Research and Treatment of Cancer - EORTC 15
Large-scale testing (Phase 3)Study completedNCT00544765
What this trial is testing

Docetaxel, Doxorubicin and Cyclophosphamide Versus Vinorelbine and Capecitabine in Patients Not Sufficiently / Sufficiently Responding as Preoperative Treatment of Locally Advanced or Operable Primary Breast Cancer

Who this might be right for
Breast Cancer
GBG Forschungs GmbH 2,014
Testing effectiveness (Phase 2)Study completedNCT00239343
What this trial is testing

Phase II Trial of Preoperative Therapy With Gefitinib and Chemotherapy in Patients With ERneg Breast Cancer

Who this might be right for
Breast Cancer
AstraZeneca 160
Testing effectiveness (Phase 2)Study completedNCT00422903
What this trial is testing

Letrozole In Combination With Lapatinib In Neoadjuvant Treatment Of Early Breast Cancer

Who this might be right for
Neoplasms, Breast
GlaxoSmithKline 92
Testing effectiveness (Phase 2)Study completedNCT01779479
What this trial is testing

Efficacy and Safety of Cabazitaxel Versus Weekly Paclitaxel as Neo-adjuvant Treatment in Patients With Triple Negative or Luminal B/HER2 Normal BC (GENEVIEVE)

Who this might be right for
Primary Breast Cancer
GBG Forschungs GmbH 333
Not applicableUnknownNCT00502684
What this trial is testing

Perioperative Administration of COX 2 Inhibitors and Beta Blockers to Women Undergoing Breast Cancer Surgery

Who this might be right for
Primary Operable Breast Cancer
Kaplan Medical Center 32